DelMar Pharmaceuticals, Inc. DMPI Company Overview  Stock

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
DelMar Pharmaceuticals, Inc. DMPI Company Overview 

Stock Message Board http://investorshangout.com/search?q=DMPI&...mp;yt1=Go!

DelMar Pharmaceuticals, Inc. DMPI Current Price and Quotes
Last Price 1.02
Previous Close 1.02 Open 1.03
Daily Range 1.08 - 1.02 52wk Range 3.40 - 1.00
Volume 15,800 Dividend N/A
Average Vol (3m) 10,622 Yield N/A
DelMar Pharmaceuticals, Inc. DMPI
Company Information

Suite 720-999 West Broadway
Vancouver, BC V5Z 1K5
Canada

Website: http://www.delmarpharma.com/
Phone: 604-629-5989

DelMar Pharmaceuticals, Inc. DMPI
DelMar Pharmaceuticals, Inc. DMPI
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0001498382
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Jeffrey Bacha CEO, President
Scott Praill CFO
Dennis Brown Chief Scientific Officer
Company Directors

Not Available
Company Notes

Formerly=Berry Only, Inc. until 1-2013
Service Providers

Auditor/Accountant
PricewaterhouseCoopers LLP
250 Howe Street
Suite 700
Vancouver, BC, V6C 3S7
Canada

Legal Counsel
Sichenzia Ross Friedman Ference LLP
61 Broadway
New York, NY, 10006
United States

Investor Relations Firm
Booke and Company, Inc.
600 3rd Ave. 2nd Floor
New York, NY, 10016
United States


DelMar Pharmaceuticals, Inc. DMPI
DMPI Security Details

Share Structure

Market Value1 $23,286,841 a/o Sep 12, 2013
Shares Outstanding 22,830,236 a/o Aug 09, 2013
Float Not Available
Authorized Shares 75,000,000 a/o Dec 31, 2010
Par Value  0.001
Shareholders

Shareholders of Record 34 a/o Sep 28, 2011
Corporate Actions

Ex. Date Record Date Pay Date
Dividend (0.00) *  Jan 24, 2013 Jan 24, 2013
Dividend (0.00) Jan 22, 2013 Jan 18, 2013 Jan 18, 2013
Security Notes

Capital Change=shs increased by 3.38983 for 1 split. Ex-date=01/22/2013. Rec date=01/18/2013. Pay date=01/18/2013.
Short Selling Data

Short Interest 1,491 (100%)
Aug 30, 2013
Significant Failures to Deliver  No
Transfer Agent(s)



DelMar Pharmaceuticals, Inc. DMPI Recent News

Sept 11, 2013 CCG Investor Relations Announces Company Presenters for NexGen Life Sciences Virtual Conference
Sept 10, 2013 NexGen Life Sciences Virtual Investor Conference Brings Companies, Analysts and Investors Together on September 12th
Sept 9, 2013 DelMar Pharmaceuticals and Guangxi Wuzhou Pharmaceuticals Establish Clinical Advisory Board in China
Sept 9, 2013 DelMar Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com September 12th
Sept 8, 2013 OTC Signal Daily Stock Watch - DelMar Pharmaceuticals (OTCQB: DMPI)
Sept 3, 2013 DelMar Pharmaceuticals To Present At The 15th Annual Rodman & Renshaw Global Investment Conference
Aug 22, 2013 DelMar Pharmaceuticals Announces Appointment of Robert J. Toth, Jr. to Board of Directors
Aug 21, 2013 DelMar Pharmaceuticals to Accelerate Glioblastoma Clinical Trial in the United States
Aug 13, 2013 DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended June 30, 2013
Aug 12, 2013 DelMar Pharmaceuticals Hosts Symposium at International Brain Tumor Meeting

1
2
next >

DelMar Pharmaceuticals, Inc. DMPI Financials
Period Ending Jun 30, 2012 Jun 30, 2011 Jun 30, 2010
Total Revenue - - -
Cost of Revenue - - -
Gross Profit - - -
Operating Expenses

Research and Development - - -
Sales, General and Admin. 19 33 6
Non-Recurring Items - - -
Other - - -
Operating Income (19) (33) (6)
Income From Continuing Operations

Add'l Income/Expense Items - - -
Earnings Before Interest and Tax (19) (33) (6)
Interest Expense - - -
Earnings Before Tax (19) (33) (6)
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (19) (33) (6)
Non Recurring Events

Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (19) (33) (6)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (19) (33) (6)

DMPI DelMar Pharmaceuticals, Inc. Research DD Guide

DMPI DelMar Pharmaceuticals, Inc. Stock Message Board http://investorshangout.com/search?q=DMPI&...mp;yt0=Go!
DMPI DelMar Pharmaceuticals, Inc. Stock Quote http://www.otcmarkets.com/stock/DMPI/quote
DMPI DelMar Pharmaceuticals, Inc. Stock Chart http://www.otcmarkets.com/stock/DMPI/chart
DMPI DelMar Pharmaceuticals, Inc. Company Info http://www.otcmarkets.com/stock/DMPI/company-info
DMPI DelMar Pharmaceuticals, Inc. Recent News http://www.otcmarkets.com/stock/DMPI/news
DMPI DelMar Pharmaceuticals, Inc. Financials http://www.otcmarkets.com/stock/DMPI/financials
DMPI DelMar Pharmaceuticals, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/DMPI/filings
DMPI DelMar Pharmaceuticals, Inc. Short Sales http://www.otcmarkets.com/stock/DMPI/short-sales
DMPI DelMar Pharmaceuticals, Inc. Insider Disclosure http://www.otcmarkets.com/stock/DMPI/insider-transactions
DMPI DelMar Pharmaceuticals, Inc. Research Reports http://www.otcmarkets.com/stock/DMPI/research
DMPI DelMar Pharmaceuticals, Inc. Summary http://finance.yahoo.com/q?s=DMPI
DMPI DelMar Pharmaceuticals, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=DMPI+Historical+Prices
DMPI DelMar Pharmaceuticals, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=DMPI
DMPI DelMar Pharmaceuticals, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=DMPI+Basic+Chart
DMPI DelMar Pharmaceuticals, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=DMPI+Basic+Tech.+Analysis
DMPI DelMar Pharmaceuticals, Inc. Headlines http://finance.yahoo.com/q/h?s=DMPI+Headlines
DMPI DelMar Pharmaceuticals, Inc. Press Releases http://finance.yahoo.com/q/p?s=DMPI+Press+Releases
DMPI DelMar Pharmaceuticals, Inc. Company Profile http://finance.yahoo.com/q/pr?s=DMPI+Profile
DMPI DelMar Pharmaceuticals, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=DMPI+Key+Statistics
DMPI DelMar Pharmaceuticals, Inc. Industry http://finance.yahoo.com/q/in?s=DMPI+Industry
DMPI DelMar Pharmaceuticals, Inc. Major Holders http://finance.yahoo.com/q/mh?s=DMPI+Major+Holders
DMPI DelMar Pharmaceuticals, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=DMPI+Insider+Transactions
DMPI DelMar Pharmaceuticals, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=DMPI+Insider+Roster
DMPI DelMar Pharmaceuticals, Inc. Income Statement http://finance.yahoo.com/q/is?s=DMPI
DMPI DelMar Pharmaceuticals, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=DMPI
DMPI DelMar Pharmaceuticals, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=DMPI+Cash+Flow&annual
DMPI DelMar Pharmaceuticals, Inc. Nasdaq http://www.nasdaq.com/symbol/DMPI
DMPI DelMar Pharmaceuticals, Inc. Market Watch http://www.marketwatch.com/investing/stock/DMPI
DMPI DelMar Pharmaceuticals, Inc. Bloomberg http://www.bloomberg.com/quote/DMPI:US
DMPI DelMar Pharmaceuticals, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=DMPI
DMPI DelMar Pharmaceuticals, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=DMPI
DMPI DelMar Pharmaceuticals, Inc. Barchart http://www.barchart.com/quotes/stocks/DMPI
DMPI DelMar Pharmaceuticals, Inc. OTC Short Report http://otcshortreport.com/index.php?index=DMPI
DMPI DelMar Pharmaceuticals, Inc. Investopedia http://www.investopedia.com/markets/stocks/DMPI/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Iberostar's Grand Move: Opening in Zanzibar

Updated Category News Views 175

The Resort That Takes Your Breath Away Here we have Iberostar, boldly wading into the azure waters of the Indian Ocean, planting its flag on the sandy beaches of Zanzibar. This isn’t just another notch on the resort’s belt—it’s their first time setting up shop in East Africa, a move ripe with promise and adventure both. A Suite So Sweet 358 suites, mind you. Each...

Continue Reading
Vuzix Bets on Lightweight Color Glasses for OEM Partners

Updated Category News Views 34

Forty grams is where this story gets interesting, because faces are ruthless product testers. People will tolerate plenty of clever technology right up until it pinches, looks goofy, leaks light, or makes them feel like they are wearing a science project. Vuzix is trying to clear that hurdle with Ultralite Color, a full-color AI eyewear reference platform built for OEM...

Continue Reading
Yeahka Bids to Lead AI Shopping Evolution

Updated Category News Views 115

AI Shopping: A New Frontier or A Sisyphean Task? The evolution of AI from sassy recommendation tools to transaction-executing agents is shaking up the retail sector. Enter Stage Left: Yeahka Limited (9923.HK), a payment tech outfit that's wading into this murky digital swamp. With YeahPay and Fushi Tech, they're trying to hammer out a blueprint for AI-friendly commerce...

Continue Reading
Sunbit’s 2027 Loan Push Meets an NVIDIA-Fueled Tape

Updated Category News Views 16

Credit Is About to Enter Sunbit’s Growth Story Sunbit has spent years building a point-of-sale fintech footprint, and the numbers it cited on November 18 make the next step harder to dismiss as mere marketing fluff. The company says it has topped 400,000 activated cardholders and 50,000 merchants, while expecting more than $440 million in fiscal 2026 sales on greater...

Continue Reading
USFM's Disko Deal Waits on Greenland Until March 2027

Updated Category News Views 211

A missing Greenland signature has turned USFM’s grand Disko plan into a calendar problem. Nothing more dramatic has been disclosed, but nothing less consequential should be assumed either. March 31 replaces a deadline that already failed USFM executed its share purchase agreement with 80 Mile PLC and Disko Exploration Limited on May 8, 2026. The proposed bargain is...

Continue Reading
Voranigo Follow-Up Deepens the Glioma Care Debate Today

Updated Category News Views 159

Brain-tumor progress rarely arrives with a clean victory lap, but the longer INDIGO readout gives clinicians and sector watchers something sturdier than a one-time headline. Servier presented extended Phase 3 results for VORANIGO, or vorasidenib, at the Society for Neuro-Oncology meeting in Philadelphia on November 14 and 15, 2026. The central message is durable benefit...

Continue Reading
Albany Masonry Waterproofing Is a Quiet Value Play

Updated Category News Views 0

Winter works its mischief one soaked brick at a time. That is the unglamorous truth behind Sean Mulligan's discussion of masonry waterproofing for Albany-area homes. Brick and stone look tough enough to outlast the furniture, the siding, maybe the whole neighborhood. Yet they are porous materials, and in a region where rain, snowmelt, and sharp temperature swings keep...

Continue Reading
Teen Adoption Campaign Makes Room for Mutual Growth

Updated Category News Views 120

A bicycle wobble and a ballet count carry more weight than they first appear to. The new Adoption from Foster Care public service ads put teens in the instructor's spot: a son helps his mother learn to ride a bike in Two Wheeler, while a daughter walks her father through ballet in Routine. It is a small creative reversal, but a smart one. Teen adoption is too often framed...

Continue Reading
Linkind's Best Buy Push Tests Smart Outdoor Demand

Updated Category News Views 77

Holiday lights have quietly become a year-round hardware category, and Linkind wants a louder seat at the table. The smart-lighting brand says three outdoor products have been in Best Buy stores across the United States since October 17, 2026: permanent exterior lights, decorative string lights, and solar pathway lights. That is a real distribution step, not some grand...

Continue Reading
Weatherford Adds Grant Roach to Its Sports Deal Team

Updated Category News Views 0

Sports investing has reached that awkward middle age where everybody sees the runway, but few can explain exactly where the bumps are. Weatherford Capital’s decision to bring Grant Roach aboard as vice president is not a headline packed with transaction fireworks. It is, however, a pretty clear tell: the Tampa firm intends to put more bodies and more underwriting muscle...

Continue Reading

Top 5 Most Recently Viewed Articles

A.B. Data Appoints Steve Straub as New Operations VP

Updated Category News Views 542

A.B. Data Appoints Steve Straub as New Operations VP A.B. Data, a prominent name in class action notice and claims administration, has elevated Steve Straub to the role of Vice President of Operations. Having served as the Senior Director of Operations since 2023, Steve brings a wealth of experience that will further strengthen the company’s operations. Strategic...

Continue Reading
Conexon Connect Expands Fiber Network for Rural Internet Access

Updated Category News Views 170

Conexon Connect's Milestone Achievement Conexon Connect has successfully completed a transformative fiber-to-the-home (FTTH) project, expanding high-speed internet access to over 12,000 members of rural electric cooperatives. This expansive network marks a significant achievement in bridging the digital divide, particularly for underserved communities. Partnerships...

Continue Reading
Xiaomi MIX Flip 2 Unveils TCL CSOT's Cutting-Edge Displays

Updated Category News Views 349

TCL CSOT Powers the Xiaomi MIX Flip 2's Display Experience TCL CSOT is making waves in the tech world by providing state-of-the-art displays for the Xiaomi MIX Flip 2. This new foldable smartphone marks a significant shift in user experiences, aligning perfectly with the growing demand for portable, high-performance devices. During a recent launch event showcasing...

Continue Reading
Immunic Showcases Promising Results for Vidofludimus Calcium

Updated Category News Views 106

Immunic Highlights Key Findings from CALLIPER Trial Immunic, Inc. (Nasdaq: IMUX), a leading biotechnology company specializing in innovative oral therapies for neurologic and gastrointestinal conditions, recently presented significant data from its Phase 2 CALLIPER trial. This trial evaluates its cornerstone therapy, vidofludimus calcium (IMU-838), aimed at treating...

Continue Reading
Amrop Expands Global Reach with New Office in Colombia

Updated Category News Views 153

Amrop Expands With a New Office in Colombia Amrop, a distinguished global executive search and leadership consulting firm, has recently announced the establishment of a new office in Colombia. This expansion marks a significant milestone for Amrop as they enhance their service offerings in Latin America. Introducing Amrop Colombia Amrop Colombia emerges from the merger...

Continue Reading